ArticlePsychiatry research2020
COVID19 pandemic and people with opioid use disorder: innovation to reduce risk.
Article in Psychiatry research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review.Substance abuse treatment, prevention, and policy · 2023Pooled it
- Alcohol and other substance use during the COVID-19 pandemic: A systematic review.Drug and alcohol dependence · 2021Pooled it
- Article
- Article
- Handling COVID-19 in the capital city of Jakarta with innovation policy: the scale of social restrictions policy.Heliyon · 2022Article
- The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.Journal of substance abuse treatment · 2022Article
- The Association of Opioid Use Disorder and COVID-19, a Longitudinal Study.International journal of preventive medicine · 2022Article
- Article
- Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review.Addiction science & clinical practice · 2021Article
- Treatment provider perceptions of take-home methadone regulation before and during COVID-19.Drug and alcohol dependence · 2021Article
- COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.Journal of general internal medicine · 2021Article
- Increased Treatment Engagement and Adherence: Flexible Management with Prolonged-Release Buprenorphine in Treatment of Opioid Dependence.Case reports in psychiatry · 2021Article
- Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?Journal of substance abuse treatment · 2020Article
- Psychological factors associated with substance use initiation during the COVID-19 pandemic.Psychiatry research · 2020Article
- Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder.Substance abuse · 2020Article
- Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment.Journal of addiction medicineArticle
- COVID-19 and addiction.Diabetes & metabolic syndromeReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Covid-19 pandemic is creating a vast and growing number of challenges for all. People with a history of opioid use disorder (OUD) also may be exposed to additional risks. Piedmont one of the areas most severely affected by the Covid-19 pandemic, with large numbers of people infected and related mortality. In the region, specialists responsible for OUD care identified the risk that the existing care system exposed patients to. Teams designed and implemented innovation approaches to enable continuation of care and reduce the inherent system risk to patients with OUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.